Skip to main content

Neuromod Devices

Dublin, Ireland

Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.

$10.9M raised
Mar 2025
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Neuromod Devices

How much funding has Neuromod Devices raised?
Neuromod Devices has raised $10.9M in total funding. The most recent round was Series B. The last funding was announced in March 2025.
Who are Neuromod Devices's investors?
Neuromod Devices's investors include European Investment Bank, Enterprise Ireland, Panakes Partners, Kreos Capital, Silicon Valley Bank.
Where is Neuromod Devices headquartered?
Neuromod Devices is headquartered in Dublin, Ireland.
What does Neuromod Devices do?
Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.
What stage is Neuromod Devices at?
Neuromod Devices is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Neuromod Devices — Funding & Investors." VCBacked, March 11, 2025, https://www.vcbacked.co/company/neuromod-devices. Accessed July 3, 2026.
APA
VCBacked. (2025). Neuromod Devices — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/neuromod-devices
Wikipedia (cite web)
{{cite web |title=Neuromod Devices — Funding & Investors |url=https://www.vcbacked.co/company/neuromod-devices |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .